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SOME UNEXPLAINED METABOLIC ACTIONS OF PITUITARY HORMONES
WITH A UNIFYING HYPOTHESIS CONCERNING THEIR SIGNIFICANCE#
The elucidation of the nature and actions of the adenohypophyseal hormones
has been a challenging problem which has been yielding to attack only very
slowly. It has been recognized for some time that there are several
adenohypophyseal hormones at least one of which, growth hormone or
somatotropin, has general systemic metabolic actions."7 All the others,
corticotropin, thyrotropin, follicle-stimulating hormone, luteinizing hormone
and prolectin or luteotropin, appear to have their actions primarily if not
solely on specific target glands. Despite substantial progress in the
morphological localization of the pituitary hormones and their chemical
purification, we still know very little either about the exact chemical
nature of these hormones as they are formed and exist in the gland, or
about their properties as they are secreted into the bloodstream. At one
time it was believed that all the pituitary hormones were protein in nature
but in recent years it has been established that biological activity of at least
one-ACTH-may be associated with a polypeptide molecule which is
much smaller than was suspected.' However, it must be borne in mind
that the mere fact that a polypeptide has biological activity does not
necessarily imply that this is the molecular form in which the hormone is
stored in the gland or is secreted. Nor can we even be certain that the
biological activities reported for the purified hormones are necessarily
those of the naturally secreted hormones. It must be appreciated that we
are dealing with properties of very complex molecules and that the multiple
biological activities of the different pituitary hormones probably depend on
specific molecular configurations of peptide chains. The chemist might
inadvertently alter these in his search for purity, thereby eliminating some
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biological activities or even endowing the molecule with new properties
which nature did not intend it to have. In short, in our studies with
pituitary hormones we need to keep an open mind and be prepared to meet
surprises. We will find it best not to be too bound by preconceived notions
as to what the pituitary hormones "ought to do."
In this lecture I propose to describe to you research which has been in
progress in our laboratory for the past six years. It began with a very
simple objective, that of elucidating the role of the adrenal cortex in
ketone body metabolism, but it has led us into some unexpected areas
relating to apparent common biological activities of several pituitary
hormones. For some time an explanation for these unexpected metabolic
actions of ACTH and other pituitary hormones has seemed to be beyond
our grasp. Recently, however, new light has been shed on the problem
largely through the opportunity of studying some relatively pure samples
of corticotropin and fractions thereof. It is my purpose in this lecture to
review some of this work and attempt to interpret it in terms of some
speculative hypotheses concerning the action of pituitary hormones. The
details of these studies will be published elsewhere."
The adrenal cortex and ketosis. Our studies began with a re-investiga-
tion of the role of the adrenal cortex in ketosis and were motivated by the
fact that the newer knowledge of the pathways of fat synthesis and
catabolism and of ketogenesis made it seem likely that a better understand-
ing of adrenal cortex action might be established thereby.'9 I will not speak
in detail of this work, much of which is published, 0 since it is not
germane to our main topic, but will simply outline the salient features.
In 1948 it was reported by Bennett et al. that ACTH had ketogenic
activity in the dog and the rat"'7'8 and, although these findings were not
uniformly confirmed,'0 it was a prevailing belief that this ketosis was
mediated by the action of adrenal cortical steroids.' Kinsell et al." were
probably the first to question this interpretation when they reported that
both cortisone and intravenously infused ACTH inhibited ketonemia in
man. Our own studies in the rat likewise showed that both cortisone and
hydrocortisone suppressed not only fasting ketosis' but also that associated
with cold exposure'0 and fluoroacetate poisoning." When ACTH was
administered four times a day to the rat during a four-day fast on the
other hand, no effect on ketonemia was observed, even though there was
obvious stimulation of the adrenal cortices, judging from the blood sugar
values. The above observations suggested that the predominant action of
ACTH in stimulating steroid secretion did not lead to ketosis but left
unexplained the reports of ketosis immediately following ACTH injection.
For this reason, observations on the acute effects of an intraperitoneal
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injection of ACTH in the rat were made and it was very quickly established
that if blood ketone levels were measured immediately after ACTH
injection and before the usual adrenal cortical response, a brisk ketonemia
could be demonstrated. In addition to the ketosis, there also was a
significant fall in blood sugar, an unexpected response to ACTH.' We
will return to this observation later.
The antiketogenic response to cortisone (and hydrocortisone) and the
ketogenic response to ACTH represented a paradox if we began with the
premise that the metabolic actions of ACTH are mediated by the adrenal
cortex unless (a) ACTH stimulates the secretion of some ketogenic
steroid rather than hydrocortisone, since the latter has been shown to be
antiketogenic, (b) the ACTH used was contaminated with some other
pituitary factor which was ketogenic, or (c) ACTH has extra-adrenal
metabolic actions.
Much time and effort were spent attempting to satisfy ourselves that the
adrenal cortex was not the mediator of the ketogenic response to ACTH.
The key experiment was the demonstration that ACTH has a ketogenic
effect in the adrenalectomized rat.' Not only was ketosis demonstrable in
the absence of the adrenals but again hypoglycemia was induced. Ketosis
was demonstrated in both DOCA and the cortisone-maintained adrenalec-
tomized rats. This experiment indicated clearly that the ACTH was itself
responsible for the ketosis and hypoglycemia. This leads us to a considera-
tion of the ketogenic and other metabolic activities of pituitary extracts
and hormones.
The ketogenic and adipokinetic factor(s). As has been recently reviewed
elsewhere,'"9 it has been known for a long time that alkaline extracts of
the pituitary gland have the property of causing fatty livers, ketosis, and a
lowering of the R.Q. The fat mobilizing activity was later dubbed the
adipokinetic activity by Weil and Stetten." With the purification of growth
hormone, attention was quickly directed to it to determine whether it was
responsible for these metabolic activities. It was soon found that purified
growth hormone did indeed have these and other activities which are
summarized herewith.
Growth hormone stimulates somatic growth as indicated by an increase
in weight and length, and by the widening of the epiphyses of the long bones
in the hypophysectomized rat. Chemically, growth is apparent in the
production of a positive nitrogen balance9' and in an increased uptake of
isotopically labelled amino acids and of S' and P8' by various tissues.
14,16, W,47 In addition, a lowering of plasma amino nitrogen has been
described"9 "'"' and Russell has shown that the conversion of infused
amino acids to urea in the nephrectomized rat is decreased by growth
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hormone treatment. ,"' Associated with the growth-promoting effects
and perhaps even primary to them are influences on general metabolism
and on fat and carbohydrate metabolism. Mobilization of fat from the
periphery to the liver with hyperlipemia and fatty liver occur and an
accelerated catabolism of fat and ketosis can be demonstrated.' The R.Q.
of the fed animal is lowered, reflecting either increased fat catabolism or
inhibition of lipogenesis or both. And finally, some striking immediate
changes in carbohydrate metabolism occur which are less well known than
the later diabetogenic action. The blood sugar level of the fasted animal is
lowered; if glucose is given simultaneously, an improved carbohydrate
tolerance is demonstrable.5' Cardiac and skeletal muscle glycogen levels
KETOGENIC EFFECT OF GROWTH HORMONE IN THE RAT
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FIG. 1. The ketogenic responlse to growth hormone following intraperitoneal injection
of the hormone in anesthetized rats. The Li, B111-60, and B168-GH were inactive in
doses less than 1.0 mg., C-35-39-J in doses less than 0.30 mg.
are increased. "' '~" With continued growth hormone treatment, diabetes
develops secondary to pancreatic islet cell exhaustion.9'
Now let us return to the problem of ketosis. Having demonlstrated that
ACTH is ketogenic and hypoglycemogenic in the adrenalectomized rat, we
must conclude that either (a) corticotropin is contaminated with growth
hormone, or (b) corticotropin has these properties itself and is "the
ketogenic factor," thereby contaminating growth hormone, or (c) both
hormones have these activities independently. For these reasons, it was
necessary to examine a considerable variety and number of samples of
pituitary hormone from different sources for their metabolic activities.
Figure 1 illustrates the ketogenic response to a number of samples of
bovine growth hormone. The first sample was prepared by Dr. C. H. Li
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and kindly supplied to us by him. Samples 22KR1 and 3PKR-3 were old
Armour preparations, while the remaining four were prepared by the Wil-
helmi technique.* B1 1-60 and B168-GH were supplied to us by Dr. A. E.
Wilhelmi and 17-A511oX by Dr. L. Mitchell of the Horner Company.
Note that the active doses were of the order of 0.1-1.0 mg. per rat and that
the magnitude of the ketogenic responses was modest.
While we were carrying through these studies, Petersen and Lotspeich
reported that TSH had greater ketogenic, adipokinetic, and hypoglycemic
activity than growth hormone and suggested that these activities in growth
hormone could be ac-
counted for by con- KETOGENIC EFFECT OF THYROTROPIN IN THE RAT
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For this reason we ex- 89* "n x 9.0O 9 4 tended our studies to z In
TSH with the follow- t z 7
X - l o _. A
ing results (Fig. 2). a w 4 8 . 7
Note that the keto- OR 2
genic activities of the zSV +3 | ||
twopreparations avail- w
able to us were of the
same general order as DN M 0 Jo .25.500 .01 .02.04 JO .25 .005
observed with growth P - .01 .01 .01 - US S .01..02.01 S.&
hormone although we FIG. 2. Ketogenic action of TSH tested as in Figure 1.
did get a response
with IRW at 0.040 mg. Triiodothyronine was inactive, suggesting, but not
proving, that the ketogenic response was not due to thyroid stimulation.
In the case of corticotropin, many observations were made, some of
which are already published.'8' Figure 3 shows some of the typical
responses to the injection of oxycel purified corticotropin obtained from
three different laboratories. Note that the minimal active dose is quite low
in mg. (0.01-0.03 mg.) and that in general the magnitude of the response
is greater than that observed with growth hormone. Note also that mild
treatment of the ACTH with alkali did not abolish the ketogenic response,
although more severe treatment by boiling in 0.1N NaOH did. We shall
return to this observation later.
At the same time as we were conducting these studies, Astwood, Raben,
Rosenberg, and Westermeyer were also investigating the metabolic actions
of oxycel ACTH.1" 8 e'8 They reported that this material not only was
ketogenic, but also had adipokinetic activity, produced hypoglycemia,
lowered the R.Q., increased oxygen consumption, and increased cardiac
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glycogen, and that all these actions were demonstrable in the absence of the
adrenal cortex. Furthermore, studies in our laboratory demonstrated an
improved tolerance to intravenously infused glucose' and an increased
conversion of octanoic acid to ketone bodies in the rat.' In short, the
studies from the two laboratories described for oxycel ACTH just about
all the metabolic activities previously attributed to growth hormone except
growth itself.
If oxycel ACTH is indeed contaminated with growth hormone, which
KETOGENIC EFFECT OF OXYCEL CORTICOTROPIN IN THE RAT
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FIG. 3. Ketogenic action of oxycel ACTH tested as in
Figure 1. The Wilson ACTH was also tested at a dose
of 0.02 mg. and found active. Note resistance to mild
alkali treatment, but loss of activity with more vigorous
treatment.
seemed unlikely as
long as it had greater
activity in producing
ketosis than did
growth hormone, it
should be possible to
demonstrate the char-
acteristic response of
growth hormone,
namely, stimulation of
growth. The conven-
tional assay for growth
hormone depends on
the ability of the hor-
mone to promote the
widening of the tibial
epiphysis in hypophy-
sectomized rats.' In
the presence of ACTH
this assay is unsatis-
factory because the
glucocorticoids secret-
ed in response to ACTH stimulation inhibit growth of the long bones at
the epiphyses. Hence the assays must be done in hypophysectomized-
adrenalectomized rats. This is a difficult and tedious procedure. Re-
cently, Russell has developed another method of demonstrating a ni-
trogen-retaining action of growth hormone.' Protein ACTH and the
glucocorticoids do not interfere in this technique. This method depends on
the fact that growth hormone decreases the conversion of amino acids to
urea when they are infused into nephrectomized rats. In 1954, we sent
Dr. Russell a sample of Astwood's oxycel ACTH to assay for nitrogen-
retaining activity by this technique. Figure 4 shows the results, which were
quite unexpected. Oxycel ACTH had clearcut N-retaining activity which
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was quite comparable to that of an active Wilhelmi growth hormone.* It
was difficult to believe that oxycel ACTH had such a great degree of
contamination with growth hormone, but at the time the experiment was
carried out this conclusion seemed inescapable.' Nevertheless, we found
this interpretation so difficult to accept that we initiated a series of studies
designed to establish whether the ketogenic activities of ACTH, growth
hormone, and TSH represented common or independent properties of the
N-RETAINING EFFECT OF G. H.AND OXYCEL ACTH
IN NEPHRECTOMIZED RATS
(Data of Dr. J. Russell)
FIG. 4. The N-retaining effect of growth hormone and oxycel ACTH as measured by
their ability to decrease the formation of urea N from an infused amino acid mixture
in two hours.
three hormones. The urgency of this is apparent when we compare in
Table 1 the common activities of the three hormones which have been
demonstrated so far.
The activities of growth hormone and ACTH are now pretty well
established; those of TSH are on a less firm basis. All three hormones
* This result has now been confirmed in this laboratory. In addition, it has been
found that both growth hormone and oxycel ACTH as well as more purified ACTH
peptides (al - a2, American Cyanamid) will depress urea formation from infused
amino acids in adrenalectomized nephrectomized rats. This metabolic response is thus
an extra-adrenal one, but it remains to establish whether it is synonymous with the
characteristic protein anabolic and growth-promoting action which is typical of growth
hormone.
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have been reported to increase the basal oxygen consumption.' In the case
of TSH, this action is mediated by the thyroid. Growth hormone and TSH
both will widen the tibial epiphysis of hypophysectomized rats, but the
latter does so by virtue of the stimulating effect of thyroid hormone.'
ACTH, of course, inhibits growth at the tibial epiphysis because of the
anti-anabolic action of the corticoids. All three hormones have been found
to lower plasma amino nitrogen levels,""" 8' 49' although the mechanism and
significance of this response remains to be established. Oxycel ACTH and
growth hormone will induce N-retention in the nephrectomized rat infused
with amino acids. Protein ACTH, however, is inactive." TSH has not
TABLE 1. COMMON METABOLIC ACTIVITIES OF PITUITARY HORMONES
Activities STH ACTH TSH
Increase BMR + + +
Widen epiphyses + +
Decrease plasma amino N + + +
N-retention-nephrx rat + + ?
Fasting hypoglycemia + + +
Increase glucose tolerance + + ?
Increase cardiac glycogen + + ?
Fat mobilization + + +
Ketogenic + + +
R.Q. depression + + +
been studied. STH and ACTH will increase glucose tolerance and cardiac
glycogen.1' ' No data are available on TSH. All three hormones will
induce hypoglycemia, mobilize fat to the liver, induce ketosis and lower the
R.Q.'' ZIt might be noted in passing that some of these activities are also
shared by prolactin.'8
Attempts to determine whether the ketogenic and adipokinetic activities
of these hormones are native to each hormone or represent contamination
of one by another have not been wholly successful but have yielded some
suggestive results. These will be published in detail elsewhere' but are
summarized briefly here. First, as noted already, the samples of ACTH
were in general active at a much smaller dose than either STH or TSH,
making it seem unlikely that the activity of ACTH was due to contamina-
tion with the others. At the same time, the reported contamination of the
STH and TSH with ACTH was likewise too slight to account for the
ketogenic activity of the former. Second, it was found that gentle treat-
ment with alkali (O.1N NaOH for 24 hours at 250) never decreased the
ketogenic and adipokinetic activities of the corticotropins (Fig. 5), but
208
Volume 30, December 1957Metabolic actions of pituitary hormones I ENGEL
frequently did abolish these activities in STH and TSH.9"" £148 The mild
alkali treatment did not destroy the ascorbic acid-depleting activity of the
ACTH but more prolonged or vigorous treatment resulted in loss of both
ketogenic and adrenal ascorbic acid-depleting activity (Figs. 3, 5). In
addition, it was found by Russell' that the mild alkali treatment of oxycel
ACTH did not eliminate the N-retaining action of the hormone, but it did
destroy this activity in growth hormone. Thyrotropic activity was not
tested after alkali treatment. Finally, there was the accidental and unex-
INFLUENCE OF O.IN NoOH ON KETOGENIC ACTIVITY OF PITUITARY HORMONES
ACTH GROWTH HORMONE TSH
WILSON WIL ELMI
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FIG. 5. Mild alkali treatment fails to diminish ketogenic and adrenal ascorbic acid-
depleting activities of ACTH but boiling in O.1N NaOH for 30 minutes does (see
Fig. 3). Ketogenic activity of growth hormone B168-GH and 17ASllOX was lost,
whereas the Li growth hormone and B111-60 resisted alkali treatment. TSH lost
ketogenic activity.
plained finding that the ketogenic activity of ACTH was 25-300 fold greater
in rats anesthetized with Nembutal, chloral hydrate, or phenobarbital than
in unanesthetized rats (Fig. 6), whereas the ketogenic potency of STH and
TSH were of the same general order irrespective of whether anesthesia
was used or not. Since the Nembutal itself stimulates fasting ketosis, we
are inclined to believe that this observation means that ACTH acts at a
different locus in metabolism than do the other hormones which stimulate
ketosis.
While these various findings are indecisive and subject to a variety of
explanations, we feel that they favor the concept that the metabolic
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activities in question are intrinsic properties of each of the hormones.
Stronger support for this interpretation with relation to ACTH was derived
from studies with peptide corticotropins and fractions thereof.
The ketogenic activities of purified corticotropins. Recently the oppor-
tunity was presented to us to test purified corticotropins through the
generosity of Dr. Paul Bell, who sent us 5 mg. of several samples of ACTH
INFLUENCE OF NEMBUTAL ON KETOGENIC RESPONSE TO PITUITARY HORMONES
+ 12.01 OXYCEL ACTH GROWTH HORMONE T SH
0 6 8 Wilhelmi 17A5110-X
MS0 10 4
FIG. 6. Comparison of ketogenic responses of ACTH, GH, and TSH in anesthetized
and unanesthetized rats. Note that blood ketone levels increase with nembutal anes-
thesia alone. With ACTH the minimal active dose was 0.02 mg. in the Nembutal
group and 0.50 mg. in the unanesthetized. With growth hormone the minimal active
dose was 0.100 mg. in both cases, while with TSH it was 0.25 mg. in both cases.
derived from the extensive and elegant characterization studies of ACTH,
carried out in the American Cyanamid Company laoaois4572 73Figure
7 shows the activity of four such specimens compared to the original oxycel
ACTH. Note that oxycel ACTH, the al a2 pooi and the y pool all had
high activity, while the BP3 and the 8-1 fractions had little or no activity
at the highest dose we could test. At the time this study was done we had
no idea what these samples represented. Only after Dr. Bell's studies on
the chemistry of corticotropin were completed and sent to us could we
interpret the data.
Figure 8 presents a flow diagram illustrating the derivation of the
samples studied and three activities that have been recorded; ACTH
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activity by the adrenal ascorbic acid depletion technique, melanocyte-
stimulating hormone activity and ketogenic activity. The first two activities
were assayed in Dr. Bell's laboratory. Before describing this fractionation,
a brief discussion of the significance of the MSH activity is indicated.
It has been known for a long time that there is a material arising in the
intermediate lobe of the pituitary gland which influences pigmentation by
dispersal of melanin granules and presumably also by promotion of melanin
synthesis. " Recently this hormone has been isolated in pure form as
a and /8 MSH and chemically characterized in two laboratories.>M'a A
KETOGENIC EFFECT OF CORTICOTROPINS IN THE RAT
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FIG. 7. See text for description.
major puzzle in the last decade has been the regular association of MSH
activity with ACTH, an association which led some to suggest that ACTH
and MSH were identical.'7'27,41,68,7 5353," However, in recent years it has
been possible to obtain MSH free of ACTH. As will be seen in the flow
diagram and from data to be presented shortly, it now seems apparent
that ACTH does have some MSH activity itself, independently of the true
melanocyte-stimulating hormone. The significance of this will become
apparent shortly.
The starting material in the fractionation was oxycellulose-adsorbed
ACTH. This material had ACTH activity of approximately 100 USP
units/mg., MSH activity, and was ketogenic at a dose of 0.020 mg. (Fig. 8).
By countercurrent distribution, this was separated into a fast moving frac-
tion T6-10 accounting for 80 per cent of the weight, 90 per cent of the
211YALE JOURNAL OF BIOLOGY AND MEDICINE
ACTH activity, and 10 per cent of the MSH activity and a slow moving
fraction with the remaining activity, i.e., 10 per cent ACTH and 90 per cent
MSH, (B1-5). The rapidly moving fraction was further divided into four
main fractions, as indicated on the flow diagram. Of these the al -a2 pool
was tested by us and found to be ketogenic at a dose of 0.010 mg. Its
ACTH and MSH activities were reported to be the same as the starting
ASCORBIC ACID DEPLETING, MSH 8 KETOGENIC ACTIVITIES OF CORTICOTROPIN FRACTIONS
OXYCEL ACTH
ACTH- 100 USPunits/mg.
MSH- +
Ketogenic at 0.020mg.
80% of wt. 20% ofwt
B(I-5)(IO%ACTH,
T(6-10)(90% ACTH,10% MSH ACTIVITY) 90% MSH ACTIVITY)
12% of wt. 49% ofwt 19% of wt 20%
ACTH -100u/mg
MSH +
cK /3 Ketogenic at 0.020mg° X
PEPSIN DIGEST CHY6RY
otd 2 3 P2 P3 P3 CIO Xl Y2 Y3
ACTH (u/mg) - 100 ? I00 100 100 100 0 100
MSH + ? + + + + 0 +
KETOGENIC 0.010mg- ? ? ? ° 0 °
DOSE 000g ~ 0 000g
ofwt.
'I Iz
ACTH- IOu/mg 0
MSH-4 + 0
Ketogenic -0* ?
0neg. at 0.100 or 0.200mg.
*slight activity ot 0.200mg. a smollest dose tested
FIG. 8. See text for description.
material. The largest fraction was designated f8-corticotropin. It was
highly purified and chemically characterized as a polypeptide containing
39 amino acids. None of this peptide, which again had the same ACTH
and MSH activities as the starting material, was available to us. However,
Dr. White of the Armour Company kindly supplied us with a sample of
corticotropin A which is believed to be identical with f8-corticotropin of
Bell. The corticotropin A had the same order of ketogenic activity as oxycel
ACTH and the al -a2 pool (Fig. 7). Of the four pepsin digestion
products of f8 corticotropin, we were able to test two lots of P3 and one of
P4. One sample of P3 showed slight ketogenic activity at 0.200 mg. but
was negative at 0.100 mg., while the second was inactive at 0.200 mg. One
mg. of P4 was available. It was tested at a dose of 0.200 mg. and found to
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have slight activity. Smaller doses could not be tested. Thus P3 and P4
had adrenal ascorbic acid-depleting and MSH activities and much decreased
ketogenic activity. The y pool had high ACTH, MSH, and ketogenic
activity. Of the slow moving fraction, 8-1 was tested. This material had
much reduced ACTH activity, no ketogenic activity at a dose of 0.200 mg.,
STRUCTURE 8 DEGRADATION OF p-ACTH a PMSH
ASCORBIC ACID DEP. 0 MSH + KETOGENIC ? P MSH 1 2 3 4i-r1 6 IT7-)A 9 -10--11-Tf131 143FTr 16 17 18
- A5p-Glu-G1y-ProLTyLyrLaMet-Glu-His-Phe-Arg-Try-Gl,-SerL-Pr*.Pro-Lys-Mp
l
03-ACTH H-SerLTyrISerI.Met-Glu-His-Phe-Arg Try-Glyj Lys.Prot-Val
1, 2 3 4 5 6 7 8 16 9 10J11L 3 ASCORBICACIDDEPRt .J _1
MSH+ \ 14 Gly
KETOGENIC 1
KETOGENC /PEPSIN FRACTION 3 5 Lys
NoOH TREATMENT ASCORBIC ACID DEP. + 16 Lys
ASCORBIC ACID DEP.R!H+ 17 Arg MSH. KETOGENIC±* 1
18 Arg KETOGENIC +
19 Pro
20 Va1
PEPSIN FRACTION 4 21 Lys
ASCORBIC ACID DEP+ 22 Va1
MSH+ I
KETOGENIC±* 23 Tyr
+ + 24 Pro
39 38 37 36 35 34 33 32 31 30 29 28 27 26 25
Ho@PbeGlu-Leu-Pro-Phe-4AaGlu-Ala-Leu.Glu-Asp.Glu-Ala-Gly-Ap
t NH MSH-O KETOGENIC-O ASCORBIC ACID DEI.O
CHYMOTRYSIN FRACTION C10
*siight activity at02o0 m,&
FIG. 9. See text for description.
and much increased MSHI activity. It is believed that f8-MSH may be an
important constituent of this fraction. From these data it is apparent that
ketogenic activity still exists in what must be quite pure ACTH poly-
peptides prepared under conditions in which it is extremely unlikely that
there could be significant contamination with other pituitary hormones.
These studies also indicate some dissociation between the structure and
function of different corticotropin peptides which is made more apparent
in Figure 9 which diagrams the structures of 8-MSH as established by
Harris and Roos' and later by Geschwind et al."' and that of fl-corti-
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cotropin as characterized by Bell and his collaborators.4""',' 8-MSH is a
polypeptide with 18 amino acids and has in common with f8-corticotropin
a sequence of seven amino acids as well as two others close by. It seems
altogether likely, as suggested by those who determined this structure, that
this sharing of amino acids accounts for the MSH activity of the
corticotropins, which has been such a puzzle in the past.*
fl-corticotropin consists of 39 amino acids with serine as the N-terminal
group and phenylalanine as the carboxyl terminal group. This structure is
essentially the same, but for minor differences, as the corticotropin peptides
characterized by others as corticotropin A and a-corticotropin.""'8 8
Moreover, it would appear that the a and y pools are made up of other
peptides with structures similar to but not identical with that of /8-corti-
cotropin. In short, there appears to be a family of corticotropin peptides
with minor structural differences but similar activities.
In Figure 9 I have attempted to correlate certain information concerning
activity and structure. /8-MSH has no corticotropic activity but has, of
course, strong melanophore-stimulating activity. (A sample of Geschwind
and Li's ,B-MSH has been found to be devoid of ketogenic activity.') Bell's
8-1 fraction, which is presumably rich in MSH, had no ketogenic activity
in a dose 10 times that which was active in the a and y pools of ACTH.
Mild alkali treatment did not abolish either ketogenic activity or adrenal
ascorbic activity.t Boiling in 0.1N NaOH for 20 minutes, however,
resulted in loss of ACTH and ketogenic activities, but, according to the
data of Bell, did not abolish MSH activity. Bell's studies indicate that this
treatment results in progressive removal of the first three N-terminal amino
acids, with progressive inactivation of ACTH. It is noteworthy that this
procedure leaves intact the portion of the molecule presumably responsible
for the MSH response.a
Pepsin digestion of /8-corticotropin does not destroy ACTH and MSH
activities, provided at least the first 25 amino acids are left intact. One
fraction, P3, consisting of 30 amino acids had no ketogenic activity, while
another had slight activity, as did a sample of P4 which consists of 29
amino acids. Since the ketogenic assays were done several years after the
original ACTH and MSH assays and insufficient material was left for
reassay, these results must be interpreted cautiously. If valid, they
represent the only case in which an apparent dissociation between adrenal
ascorbic acid depleting and ketogenic action could be demonstrated. Such
* The structure of a-MSH has recently been elucidated by Harris and Learner la
and found to have a sequence of 13 amino acids corresponding to those of f8-ACTH.
t We are indebted to Dr. George Sayers for the assay of the a,- a2 pool for
adrenal ascorbic acid depleting activity.
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a dissociation has already been noted for MSH and ACTH activities
following alkali treatment of ACTH. The finding that the pepsin digest
peptide had little or no ketogenic activity led us to wonder whether
ketogenic activity might reside in the portion of the molecule which is
destroyed by pepsin. We were fortunate to obtain from Dr. Bell a small
amount of a chymotrypsin digestion product of 8-corticotropin, designated
C-10 and comprising the peptide chain from 15-37. This material was
known to have no ACTH or MSH activity. On testing, it was found to be
devoid of ketogenic activity also.
These studies with essentially pure ACTH peptides leave little doubt that
the ketogenic as well as probably the other metabolic activities described for
oxycel corticotropin must be native to the corticotropin molecule and as such
demand explanation. How can
we reconcile the systemic ACTIONS OP ACTS ON ADRENAL CMTRE
metabolic actions of ACTH
with what we know of its cHOLESTROL
action on the adrenal cortex? NEUTRAL PAT FATACIDS-S ACETL-CA
I think it can be done. What B4P sEUN ISEBS CYCLZ
I am now about to present GLUCOSE ATP_ CLUCOSE6 P0P GLYCOLYS13t
represents a unifying hypothe-
sis concerning certain common AMINO ACIDS 4PROTEIN
and unexplained actions of FIG. 10.
pituitary hormones.
A number of attempts have been made to localize ACTH action to one or
another locus of action in steroidogenesis," 7"' but these interpreta-
tions do not seem entirely satisfactory in view of the diverse actions of
ACTH which have been recorded. Any concept of ACTH action must
reconcile stimulation of growth of the gland (protein anabolism), neutral
fat, and cholesterol depletion, ascorbic acid depletion, glycogen loss,'
increased carbohydrate utilization and oxidation"'42-' and C19 and C21
steroidogenesis. Figure 10 summarizes some of these responses to ACTH
and their possible interrelationships. The cholesterol content of the gland
is lowered by ACTH treatment and probably is a source of corticoids.
Neutral fat is depleted and in all likelihood is converted to fatty acids and
thence to acetoacetyl CoA and acetyl-CoA which are the precursors of
steroids. Glucose is utilized by glycolysis and the Krebs cycle,' but also
there is an active HMP shunt which must be one source of the TPNH
necessary for steroidogenesis.' Haynes and Berthet' have recently indi-
cated that phosphorylase activity is stimulated by ACTH and triggers
glycogen breakdown and glucose utilization via the HMP shunt. Finally,
as would be anticipated from the growth of the gland, ACTH stimulates
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the uptake of C14 acetate and amino acids into protein,'a, and increases
the amount of RNA in the gland.
la At the moment we can visualize no
single mechanism of action of ACTH which would account for all these
responses unless it be one involving the reorganization and realignment of
the subcellular components of the cell making for a new level of cellular
activity.
Irrespective of what might be the mechanism of action of ACTH on the
adrenal cortex, it is obvious that many of the metabolic reactions just
ANALOGOUS ACTIONS OF ACTH ON ADRENAL a
EXTRA-ADRENAL TISSUE METABOLISM
ACTH
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02 CONSUMPTION -+
PSIUPTAKE ----------------- +
PROTEIN METABOLISM
PROTEIN ANABOLISM ---------- +
(Mitosis, Growth, Uptoke
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CARBOHYDRATE METABOLISM
INCREASED GLUCOSE USE ------ +
(Glycolysis, HMP Shunt,
Krebs Cycle)
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(11,17,21 Hydroxylotions)
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FIG. 11. See text for description.
described are analogous to those reported as extra-adrenal activities of
ACTH. On the basis of such analogies, a speculative hypothesis is proposed
and diagrammed in Figure 11.
It is suggested that under physiological conditions ACTH secreted by
the adenohypophysis acts primarily, if not exclusively, on the adrenal
cortex, either because (a) this gland has a much greater sensitivity to the
hormone or (b) because the gland fixes the hormone specifically, or
perhaps (c) because the hormone is secreted as a protein and the adrenal
has the most active specific enzyme system necessary to convert ACTH
protein to the active peptide. When the hormone is administered in great
excess, as in our experiments in which one or more U.S.P. units were used
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in the rat (even though the dose was as little as 0.010 mg.), or possibly
when it is secreted in excess, as after adrenalectomy, it may exert actions
on extra-adrenal tissues. Thus, ACTH stimulates oxygen consumption
and P32 uptake-
' - in the adrenal cortex and reputedly also increases
02 consumption in the adrenalectomized animal.' ACTH stimulates pro-
tein anabolism in the adrenal cortex and we have presented evidence that
it may, under special circumstances, have an action on extra-adrenal tissues
which is identical with one caused by growth hormone. The increase in
carbohydrate utilization in the adrenal cortex finds its analogy in the
induction of hypoglycemia, increased glucose tolerance, and enhanced
cardiac muscle glycogen. The fat "mobilization" and probable fat catabol-
ism in the adrenal cortex are reminiscent of the adipokinetic activity, the
increased oxidation of octanoic acid,' and the R.Q. depression.* The
adrenal cortex converts acetate to steroids. In the liver, acetate is probably
converted primarily to acetoacetate under the extra-adrenal influence of
ACTH. Acetoacetyl-CoA is considered as a precursor of steroids,' but
the liver has an active deacylase which favors release of free acetoacetate
into the bloodstream and hence ketosis develops.""9 Finally, key steps in
the synthesis of corticoids are those of 11, 17, and 21 hydroxylations which
have been shown to involve actual transfer of oxygen.'M It is of more than
passing interest that the first step in melaninogenesis, the conversion of
tyrosine to DOPA, involves an identical type of oxygen transfer.' It is
tempting to speculate that the increase in pigmentation in Addison's disease
may be based on a perverted action of ACTH resulting in a stimulation of
melanin synthesis in the skin instead of corticosteroidogenesis. It is in-
teresting to note in passing that many of the above reactions attributed to
the actions of ACTH on extra-adrenal tissues would be neutralized by the
action of hydrocortisone and hence would not be anticipated to be operative
except in the absence of the adrenals or immediately after a very large dose
of ACTH in the intact animal and before the biological actions of the
secreted steroids would be manifest.**
*Recent, unpublished observations show that both growth hormone and oxycel
ACTH will lower the fat content of the testicular fat pad of the fasted mouse and will
increase the glycogen content of the dorsal brown fat pad of the fed rat. Adrenalec-
tomized animals will stimulate the release of free fatty acids from adipose tissue
in vitro.
** In this regard the recent report of Teodorum' is of interest. This investigator has
found a difference in the response of brown adipose tissue of hamsters to cortisone
and "stress" both with respect to its metabolism and its response to poliomyelitis virus.
He suggests that the initial "stress" response is due to ACTH and can be reproduced
with exogenous ACTH while the opposite later reaction to stress is influenced by
corticoids and can be mimicked by cortisone treatment. If these observations can be
confirmed, they would represent the first example of a presumed extra-adrenal tissue
and metabolic response to endogenous ACTH.
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The above formulation is, of course, highly speculative and is intended
primarily to serve as a stimulus for future investigation. Most of the
suggestions made are subject to experimental verification and a number
are currently under investigation in this laboratory. Moreover, although
most of the experimental work has been directed to corticotropin, the
concept that this hormone's specific metabolic stimulating activity may be
expressed on tissues other than its target gland would seem applicable to
other pituitary tropic hormones. In final analysis, they are all "growth and
metabolic" hormones for their target glands, and in this respect it should
not be surprising that they share some activities in common with the
systemic growth hormone, STH, since each gland, in addition to its specific
activities, has general metabolic activities comparable to those of other
tissues.
TSH has been studied in greatest detail and we have already described
certain actions in common with ACTH and STH, but the basis for these
actions is less readily discernible. TSH has a well-known extrathyroidal
action on connective tissue and the orbit in myxedema and presumably in
thyrotropic ophthalmopathy. Since thyroid colloid and myxedema protein
contain the same amino sugars,' one might speculate that the accumulation
of hyaluronic acid in the orbit and elsewhere in myxedema and thyrotropic
ophthalmopathy represents a perverted extrathyroidal action of TSH
similar to that which we postulated for the action of ACTH in skin
pigmentation in Addison's disease.* Prolactin, which is an anabolic
hormone for the breast, also has some actions in common with STH.'5 It is
intriguing that prolactin is reported to increase the width of the tibial
epiphysis of the hypophysectomized male rat but not the female.' Does
the male animal have less "target" tissue for prolactin to act upon? Diligent
search will undoubtedly uncover other examples of common actions of
pituitary hormones.
In conclusion, I would like to emphasize again that the elucidation of
some of the extra-adrenal actions of ACTH may depend on the fact that
the chemists have made available active peptides which might elicit some
of these actions more readily than a native protein hormone. In addition,
these studies with the biologically active corticotropin peptides indicate
that we are on the threshold of a whole new field in endocrinology, the
correlation between hormone action and peptide structure. We can now
envision the possibility of tailoring peptide molecules to yield specific
* This suggestion is made less attractive by the recent demonstration by Gabrilove
and Ludwig"b that mucopolysaccharide accumulates in the skin in both primary and
secondary (pituitary) myxedema and in each case can be eliminated by thyroid
treatment.
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metabolic activities. It is not at all unreasonable, for example, to envisage
the possibility of deriving from ACTH, or even synthesizing, a peptide
which has growth activity but not steroidogenic activity. The future holds
much promise in this new field.
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